DNA methylation dynamics in health and disease

Y Bergman, H Cedar - Nature structural & molecular biology, 2013 - nature.com
DNA methylation is an epigenetic mark that is erased in the early embryo and then re-
established at the time of implantation. In this Review, dynamics of DNA methylation during …

Programming of DNA methylation patterns

H Cedar, Y Bergman - Annual review of biochemistry, 2012 - annualreviews.org
DNA methylation represents a form of genome annotation that mediates gene repression by
serving as a maintainable mark that can be used to reconstruct silent chromatin following …

The mighty mouse: genetically engineered mouse models in cancer drug development

NE Sharpless, RA DePinho - Nature reviews Drug discovery, 2006 - nature.com
Deficiencies in the standard preclinical methods for evaluating potential anticancer drugs,
such as xenograft mouse models, have been highlighted as a key obstacle in the translation …

SIRT1 is significantly elevated in mouse and human prostate cancer

DM Huffman, WE Grizzle, MM Bamman, J Kim… - Cancer research, 2007 - AACR
Evidence suggests that the histone deacetylase, SIRT1, is a mediator of life span extension
by calorie restriction; however, SIRT1 may paradoxically increase the risk of cancer. To …

[HTML][HTML] Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity

X Wang, Q Cao, L Yu, H Shi, B Xue, H Shi - JCI insight, 2016 - ncbi.nlm.nih.gov
Obesity is associated with increased classically activated M1 adipose tissue macrophages
(ATMs) and decreased alternatively activated M2 ATMs, both of which contribute to obesity …

A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases

R Benetti, S Gonzalo, I Jaco, P Muñoz… - Nature structural & …, 2008 - nature.com
Dicer initiates RNA interference by generating small RNAs involved in various silencing
pathways. Dicer participates in centromeric silencing, but its role in the epigenetic regulation …

Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation

C Zhang, ZY Su, TO Khor, L Shu, ANT Kong - Biochemical pharmacology, 2013 - Elsevier
Growing evidence suggests epigenetic alteration is involved during the development and
progression of prostate cancer. Previously, we found Nrf2, a key regulator of cellular …

The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis

C Dees, I Schlottmann, R Funke, A Distler… - Annals of the …, 2014 - ard.bmj.com
Objectives Activated Wnt signalling with decreased expression of endogenous inhibitors has
recently been characterised as a central pathomechanism in systemic sclerosis (SSc) …

Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice

S Yu, TO Khor, KL Cheung, W Li, TY Wu, Y Huang… - PloS one, 2010 - journals.plos.org
Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) is a transcription factor which regulates
the expression of many cytoprotective genes. In the present study, we found that the …

Tumor models for efficacy determination

BA Teicher - Molecular cancer therapeutics, 2006 - AACR
The first in vivo tumor models were developed in the mid-1960s. These models were mouse
leukemia models grown as ascites. The growth pattern was like that of bacteria in vivo and …